How much revenue does Plant-Based Investment make?

Plant-Based Investment reported -3.54 million CAD in revenue for fiscal year 2021. In Q3 2022 revenue was -3.60 million CAD.

What companies are similar to Plant-Based Investment?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Neptune Wellness Solutions Inc. (NEPTF), Tengion, Inc. (TNGNQ), Nabriva Therapeutics plc (NBRVF), Targeted Medical Pharma, Inc. (TRGM).

Plant-Based Investment Corp. (CWWBF) Stock

About Plant-Based Investment Corp.

Plant-Based Investment Corp. is no longer investing. It is a principal investment firm. The firm seeks to invest in cannabis industry. It also invests in public cannabis companies. The firm employs fundamental analysis along with a combination of bottom-up and top-down stock picking approach to create its portfolios. Cannabis Growth Opportunity Corporation is based in Toronto, Canada.

At a glance

Plant-Based Investment reported revenue of -3.54 million CAD for fiscal year 2021, and net income of -7.79 million CAD. In Q3 2022 (the quarter ended July 31, 2022) revenue was -3.60 million CAD.

Figures from company filings; latest fiscal year ended October 31, 2021.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.